Association Between Serum Levels of the Soluble Receptor (sRAGE) for Advanced Glycation Endproducts (AGEs) and their Receptor (RAGE) in Peripheral Blood Mononuclear Cells of Children with Type 1 Diabetes Mellitus

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Pediatric Endocrinology & Metabolism (JPEM)

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1515/JPEM.2009.22.10.895PMID 20020577
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Calcium-regulated intramembrane proteolysis of the RAGE receptor.

  2008cited by this paper
• The Role of Ionotropic Glutamate Receptors in the Nucleus Raphe Magnus on Hypercapnia‐induced Hyperpnea and Regulated Hypothermia

  2008cited by this paper
• Frequency of secondary dyslipidemia in obese children

  2008cited by this paper
• A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane‐bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)

  2008cited by this paper
• Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients

  2008cited by this paper
• Soluble RAGE blocks scavenger receptor CD36‐mediated uptake of hypochlorite‐modified low‐density lipoprotein

  2007cited by this paper
• The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond.

  2005cited by this paper
• Increased serum concentrations of soluble receptor for advanced glycation endproducts in patients with type 1 diabetes.

  2005cited by this paper
• Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications.

  2005cited by this paper
• Vascular complications in diabetes mellitus: the role of endothelial dysfunction.

  2005cited by this paper
• Clinical implications of Nε‐(carboxymethyl)lysine, advanced glycation end product, in children and adolescents with type 1 diabetes

  2005cited by this paper
• Soluble levels of receptor for advanced glycation endproducts (sRAGE) and coronary artery disease: the next C-reactive protein?

  2005cited by this paper
• Advanced glycation endproducts--role in pathology of diabetic complications.

  2005cited by this paper
• Purification and Characterization of Mouse Soluble Receptor for Advanced Glycation End Products (sRAGE)*

  2004cited by this paper
• Intervention against the Maillard reaction in vivo.

  2003cited by this paper
• Molecular motors

  2003cited by this paper
• Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl)lysine ELISA.

  2003cited by this paper
• Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.

  2003cited by this paper
• Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders.

  2003cited by this paper
• RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice

  2002cited by this paper
• N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins.

  1995cited by this paper
• Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins.

  1994cited by this paper

• Association between the soluble receptor for advanced glycation end products and diabetes mellitus: systematic review and meta-analysis

  2024cites this paper
• Non-invasive determination of glycation-end-products as a diagnostic method for predicting the occurrence of the anterior abdominal wall hernias

  2020cites this paper
• The role of soluble receptor for advanced glycation end-products (sRAGE) in the general population and patients with diabetes mellitus with a focus on renal function and overall outcome

  2020cites this paper
• Targeting the receptor for advanced glycation end products (RAGE) in type 1 diabetes

  2020cites this paper
• Circulating soluble RAGE and cell surface RAGE on peripheral blood mononuclear cells in healthy children

  2018cites this paper
• Elevated endogenous secretory receptor for advanced glycation end products (esRAGE) levels are associated with circulating soluble RAGE levels in diabetic children

  2017cites this paper
• Genetic variants in the receptor for advanced glycation end products (RAGE) gene were associated with circulating soluble RAGE level but not with renal function among Asians with type 2 diabetes: a genome-wide association study.

  2016cites this paper
• Serum sRAGE as a Potential Biomarker for Pediatric Bronchiolitis: A Pilot Study

  2015cites this paper
• Effects of bone marrow MSCs transfected with sRAGE on the intervention of HMGB1 induced immuno-inflammatory reaction.

  2015cites this paper
• Decrease in Circulating Concentrations of Soluble Receptors for Advanced Glycation End Products at the Time of Seroconversion to Autoantibody Positivity in Children With Prediabetes

  2015cites this paper
• Postprandial sRAGE levels in type 1 diabetes mellitus in children and adolescents.

  2015influential citation
• Circulating Concentrations of Soluble Receptor for AGE Are Associated With Age and AGER Gene Polymorphisms in Children With Newly Diagnosed Type 1 Diabetes

  2014cites this paper
• RAGE controls leukocyte adhesion in preterm and term infants

  2014cites this paper
• RAGE receptor and its soluble isoforms in diabetes mellitus complications

  2013influential citation
• Protective mechanisms against oxidative stress and angiopathy in young patients with diabetes type 1 (DM1)

  2013cites this paper
• Effect of insulin on the soluble receptor for advanced glycation end products (RAGE)

  2013cites this paper
• Regulation of Cartilage and Bone Metabolism by Oxidative Stress

  2013cites this paper
• Value of RAGE as a circulating biomarker : from sRAGE to anti-sRAGE autoantibodies

  2013cites this paper
• Threshold serum concentrations of tumour necrosis factor alpha (TNFα) as a potential marker of the presence of microangiopathy in children and adolescents with type 1 diabetes mellitus (T1DM).

  2013cites this paper
• Soluble RAGE and malondialdehyde in type 1 diabetes patients without chronic complications during the course of the disease

  2012cites this paper
• RAGE Expression in Human T Cells: A Link between Environmental Factors and Adaptive Immune Responses

  2012cites this paper
• The functional (cid:1) 374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn’s disease

  2011cites this paper
• Circulating endothelial progenitor cells and large artery structure and function in young subjects with uncomplicated Type 1 Diabetes

  2011cites this paper
• The functional -374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn's disease.

  2011cites this paper
• Physiology and pathophysiology of nitrosative and oxidative stress in osteoarthritic joint destruction.

  2011cites this paper
• glycation end products (RAGE) may modulate Crohn's disease

  2011cites this paper
• Oxidative stress in secondary osteoarthritis: from cartilage destruction to clinical presentation?

  2010cites this paper